TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
04 06 2019
Historique:
pubmed: 18 5 2019
medline: 24 3 2020
entrez: 18 5 2019
Statut: ppublish

Résumé

Thioredoxin reductase-1 (TrxR1)-, glutathione reductase (Gsr)-, and Nrf2 transcription factor-driven antioxidant systems form an integrated network that combats potentially carcinogenic oxidative damage yet also protects cancer cells from oxidative death. Here we show that although unchallenged wild-type (WT), TrxR1-null, or Gsr-null mouse livers exhibited similarly low DNA damage indices, these were 100-fold higher in unchallenged TrxR1/Gsr-double-null livers. Notwithstanding, spontaneous cancer rates remained surprisingly low in TrxR1/Gsr-null livers. All genotypes, including TrxR1/Gsr-null, were susceptible to

Identifiants

pubmed: 31097586
pii: 1903244116
doi: 10.1073/pnas.1903244116
pmc: PMC6561278
doi:

Substances chimiques

Antioxidants 0
NF-E2-Related Factor 2 0
Glutathione Reductase EC 1.8.1.7
Thioredoxin Reductase 1 EC 1.8.1.9
Txnrd1 protein, mouse EC 1.8.1.9
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11408-11417

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM110732
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG040020
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA152559
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK123738
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG055022
Pays : United States
Organisme : NIH HHS
ID : R21 OD026444
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA215784
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103474
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Toxicol Pathol. 2000 Mar-Apr;28(2):215-25
pubmed: 10805139
Free Radic Biol Med. 2000 May 1;28(9):1387-404
pubmed: 10924858
Biochemistry. 2000 Oct 24;39(42):13005-11
pubmed: 11041866
Br J Cancer. 1953 Mar;7(1):68-72
pubmed: 13051507
Annu Rev Nutr. 2004;24:539-77
pubmed: 15189131
Toxicol Sci. 2004 Dec;82(2):367-73
pubmed: 15342956
Trends Mol Med. 2004 Nov;10(11):549-57
pubmed: 15519281
Cell. 2005 Jul 1;121(7):977-90
pubmed: 15989949
Biochem Biophys Res Commun. 2006 Jan 6;339(1):79-88
pubmed: 16293230
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10544-51
pubmed: 16807293
Cell Cycle. 2006 Sep;5(17):1940-5
pubmed: 16940754
Toxicol Appl Pharmacol. 2006 Dec 15;217(3):289-98
pubmed: 17078987
Science. 2007 Jul 6;317(5834):121-4
pubmed: 17615358
N Engl J Med. 2007 Nov 8;357(19):1974-6
pubmed: 17989393
J Biol Chem. 2008 Jun 20;283(25):17147-57
pubmed: 18442974
Toxicol Sci. 2009 Mar;108(1):35-47
pubmed: 19129213
Carcinogenesis. 2009 Jun;30(6):1024-31
pubmed: 19386581
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
pubmed: 19478820
PLoS One. 2009 Jul 07;4(7):e6158
pubmed: 19584930
Curr Stem Cell Res Ther. 2010 Mar;5(1):74-80
pubmed: 19951255
J Biol Chem. 2010 Mar 12;285(11):8463-71
pubmed: 20061377
Free Radic Res. 2010 Apr;44(4):441-53
pubmed: 20166883
Cell. 2011 Jan 7;144(1):27-40
pubmed: 21215367
Carcinogenesis. 2011 Aug;32(8):1162-6
pubmed: 21606321
Nature. 2011 Jul 06;475(7354):106-9
pubmed: 21734707
Toxicol Sci. 2011 Oct;123(2):590-600
pubmed: 21775727
Eur J Pharmacol. 2011 Nov 30;670(2-3):333-40
pubmed: 21968144
J Transl Med. 2011 Oct 10;9:171
pubmed: 21985599
N Engl J Med. 2011 Sep 22;365(12):1118-27
pubmed: 21992124
Free Radic Biol Med. 2012 Aug 15;53(4):758-68
pubmed: 22684020
Nature. 2012 Sep 27;489(7417):519-25
pubmed: 22960745
Front Oncol. 2012 Dec 26;2:200
pubmed: 23272301
Free Radic Biol Med. 2013 Apr;57:119-31
pubmed: 23275004
Front Med. 2013 Jun;7(2):242-54
pubmed: 23681888
Free Radic Biol Med. 2013 Oct;63:369-80
pubmed: 23743293
J Biol Chem. 2014 Mar 28;289(13):8735-41
pubmed: 24515117
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4472-7
pubmed: 24567396
Cell Signal. 2014 Jul;26(7):1604-15
pubmed: 24705025
Cancer Lett. 2014 Aug 28;351(1):64-71
pubmed: 24944078
Adv Cancer Res. 2014;122:281-320
pubmed: 24974185
Cancer Cell. 2015 Feb 9;27(2):211-22
pubmed: 25620030
Methods Mol Biol. 2015;1267:165-83
pubmed: 25636469
Nat Commun. 2015 Mar 20;6:6479
pubmed: 25790857
Lab Anim. 2015 Apr;49(1 Suppl):59-69
pubmed: 25835739
World J Hepatol. 2015 May 8;7(7):968-79
pubmed: 25954479
Antioxid Redox Signal. 2015 Oct 1;23(10):823-53
pubmed: 26058897
Redox Biol. 2015 Aug;5:347-357
pubmed: 26122399
Cell. 2016 Aug 11;166(4):963-976
pubmed: 27477511
Cancer Res. 2017 Sep 15;77(18):4797-4808
pubmed: 28655791
Cell Rep. 2017 Jun 27;19(13):2771-2781
pubmed: 28658624
Oxid Med Cell Longev. 2017;2017:8541064
pubmed: 28785378
J Biol Chem. 2017 Oct 13;292(41):16817-16824
pubmed: 28842501
Nat Med. 2017 Nov;23(11):1362-1368
pubmed: 28967920
Sci Transl Med. 2018 Feb 14;10(428):null
pubmed: 29444979
Free Radic Biol Med. 2018 Nov 1;127:248-261
pubmed: 29609022
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
Hepatology. 2019 Apr;69(4):1768-1786
pubmed: 30561826
Carcinogenesis. 1986 Oct;7(10):1621-4
pubmed: 3757165
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
pubmed: 5279523
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5258-65
pubmed: 7777494
Mol Carcinog. 1993;8(2):67-73
pubmed: 8104413
Dev Biol. 1976 Jun;50(2):249-63
pubmed: 819316
Pharmacol Ther. 1996;71(1-2):57-81
pubmed: 8910949
Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
pubmed: 9240432

Auteurs

Michael R McLoughlin (MR)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.

David J Orlicky (DJ)

Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.

Justin R Prigge (JR)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.

Pushya Krishna (P)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.

Emily A Talago (EA)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.

Ian R Cavigli (IR)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.

Sofi Eriksson (S)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.
Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden.

Colin G Miller (CG)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.
Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59718.

Jean A Kundert (JA)

Animal Resources Center, Montana State University, Bozeman, MT 59718.

Volkan I Sayin (VI)

Department of Pathology, New York University School of Medicine, New York, NY 10016.
Department of Clinical and Molecular Medicine, University of Göteborg, 405 30 Göteborg, Sweden.

Rachel A Sabol (RA)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.
Tulane School of Medicine, Tulane University, New Orleans, LA 70112.

Joshua Heinemann (J)

Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59718.

Luke O Brandenberger (LO)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.

Sonya V Iverson (SV)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718.

Brian Bothner (B)

Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59718.

Thales Papagiannakopoulos (T)

Department of Pathology, New York University School of Medicine, New York, NY 10016.
Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.

Colin T Shearn (CT)

Anschutz Medical Campus, University of Colorado Denver, Aurora, CO 80045.

Elias S J Arnér (ESJ)

Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden.

Edward E Schmidt (EE)

Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59718; eschmidt@montana.edu.
McLaughlin Research Institute, Great Falls, MT 59405.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH